The Singapore hall smelled of chilled air and carpet adhesive, the kind of new construction that hadn’t finished off-gassing. Sean stood beside me near the service entrance, his collar pressed flat for once, his watch catching the overhead light every time he checked it.

“They’re here,” he said.

I followed his glance toward the side corridor. Mr. and Mrs. Huang had dressed carefully, his jacket too heavy for the climate, her blouse fastened to the top button. Mr. Liao wore the same side part as his son, the hair thinner now, and Mrs. Liao kept one hand on her husband’s elbow. None of them looked at the presentation hall doors.

We’d arranged the small conference room off the lobby, away from the roadshow setup. I’d put water glasses on the table and removed the investor deck printouts. The room held six chairs and a phone that didn’t ring.

Mrs. Huang sat first. She placed her bag on the floor beside her chair, then picked it up again and set it on her lap. Mr. Huang stayed standing until Sean pulled out a chair for him.

“Thank you for coming,” Sean said. He didn’t add anything else. He didn’t say he was sorry, or that he understood, or that their sons had been valued members of the team. I watched him stop himself before each of those sentences.

I opened the folder and set out the documents. The research foundation charter came first, its articles of incorporation stamped and registered. Then the safety council’s operating rules, with the halt-authority clause highlighted. Then the board reporting structure, which gave the council a direct line independent of the CEO.

“These are the foundations,” I said. “One in Kai’s name, one in Wei’s. They fund independent safety research. The council that oversees them has the authority to stop any test, at any time, and report directly to the board.”

Mr. Liao pulled the charter closer. He read slowly, one finger tracking the lines. His wife watched his face, not the paper.

“Who sits on this council?” Mr. Huang asked.

“Three people,” I said. “A materials engineer, a cardiologist, and myself. None of us report to Sean for those decisions.”

“And if you disagree?”

“The work stops until the disagreement is resolved. The charter doesn’t give the CEO a tiebreaker.”

Mr. Huang looked at Sean. “You agreed to this.”

“I signed it,” Sean said. “Fifty-three days after the explosion. I should have built it years earlier.”

Mrs. Liao’s hand tightened on her bag. She hadn’t spoken since she entered the room. Now she looked at me, not at Sean, and her gaze stayed there a long time before she said, “Will it last?”

“It’s enforceable,” I said. “The board has a copy. The investors have a copy. If anyone tries to dismantle it, there’s a record.”

“Records didn’t save my son.”

The room went very still. The air conditioning clicked on and a vent rattled somewhere above the ceiling tiles. I didn’t try to answer her. There wasn’t an answer that belonged in that silence.

Mr. Huang reached across the table and took his wife’s hand. He held it for a moment, then turned back to the charter.

“We want the foundation board to include one parent from each family,” he said. “Rotating terms. And we want the council’s halt reports copied to us.”

I looked at Sean. He nodded once.

“That can be drafted as an amendment,” I said. “We’ll have it ready before the listing closes.”

Mrs. Liao picked up the charter and read the halt-authority clause herself. Her lips moved slightly. When she set it down, she aligned its edge with the table’s seam.

“You understand,” she said, still looking at the paper, “that we are not forgiving you.”

Sean’s hand found the edge of the table. He didn’t rub his watch. He didn’t speak.

“We understand,” I said.

She nodded once and stood. The meeting was over.

* * *

The presentation hall filled in stages. First the analysts with their tablets and their quiet conversations, then the fund managers in jackets that fit them properly, then Victor Chen, who entered alone and took a seat in the third row with his phone face-down on his knee.

I stood at the podium and walked through the clinical evidence. The NTU Hospital procedure record went up on the screen, impedance readings at half-second intervals, the calcified occlusion and the moment flow restored at 14:31. I showed the catheter’s casing adhesion results, all three samples above ninety-three percent. Then I switched to the biometric band.

“The fail-safe optical sensor was rebuilt under the same validation protocol,” I said. “Every test logged, every batch traceable. The band doesn’t get a lower standard because it’s a consumer device.”

A fund manager in the second row raised her pen. “And the Nangang incident?”

Sean stepped forward before I could answer. He stood at the edge of the stage, not behind the podium, and when he spoke his voice carried to the back of the room without the microphone.

“I ordered the unverified battery cells used in that test,” he said. “I didn’t check their sourcing. I didn’t wait for the safety review. Two people died because I treated a deadline as more important than their lives.”

The room didn’t move. Victor’s phone stayed face-down.

“The safeguards we’ve built since then give every employee the authority to stop work they believe is unsafe. That authority is binding. It doesn’t pass through me. It doesn’t wait for my approval. It’s in the company’s charter, and it’s reported directly to the board.”

The fund manager wrote something on her pad. The analyst beside her stared at Sean’s hands, which hung at his sides, still.

Victor rose when the presentation ended and walked to the side of the stage. His suit was a darker grey than the one I remembered, and he’d changed his watch. He waited until the analysts had drifted toward the coffee station before he spoke.

“The dual listing will proceed,” he said. “Hong Kong and Singapore. The term sheet has been revised to include both products. Your safety council’s charter is attached as a governance appendix.”

“You’re comfortable with that?” I asked.

“I’m comfortable with enforceable oversight. It reduces my downside.” He picked up his phone. “The bell schedules will be sent to you tonight. Hong Kong first, then Singapore the following morning.”

He left through the side door, and the hall felt larger without him in it.

* * *

I found Sean in the corridor outside the conference room where we’d met the parents. He was looking at his phone, and when I stopped beside him he turned the screen toward me.

The Hong Kong listing confirmation sat at the top of his inbox. Below it, the Singapore exchange had sent the opening ceremony schedule, the time zone conversions already calculated, the dress code noted in a footnote.

“Both bells,” he said.

I looked at the screen. The two confirmations sat one above the other, identical in format, different in time zone, and neither one mentioned Kai or Wei. Neither one mentioned the charter or the council or the parents’ amendment that I still needed to draft. They were just confirmations. Transactional. Clean.

And they were enforceable. That was the difference. The confirmations didn’t offer absolution, and they didn’t pretend to. They offered a structure that would outlast any single person’s judgment, and I realized, standing in that corridor with the carpet adhesive still sharp in the air, that I didn’t need them to do anything else.

“I’ll draft the amendment tonight,” I said.

Sean pocketed his phone. “I’ll review it.”

“The council reviews it. You get a copy.”

He looked at me for a moment, and then he nodded. “The council reviews it.”

The corridor led back toward the hall, where the last of the analysts were packing their bags and the coffee station was being cleared. I could hear the clink of cups and the low murmur of a conversation I didn’t need to join. Tomorrow the bells would ring, first in Hong Kong and then in Singapore, and after that the work would continue under rules that didn’t depend on any single person keeping them.

I walked toward the service entrance, where the afternoon light was coming through the glass doors in a long clean slant, and I took out my phone to start the draft.

The procedure room at NTU Hospital was smaller than I’d expected, white-walled and dense with equipment that had been wheeled into a careful semicircle around the table. Dr. Kuan-Yu Chen stood at the monitor bank with his back to me, the narrow black frames of his glasses catching the glow of the imaging screen. He had not spoken since the patient was prepped, and the only sound was the low rhythmic beep of the vitals monitor and the click of a nurse’s shoes on the sealed floor as she adjusted an IV line.

I stood near the door with the procedure record open on a portable stand, my pen uncapped but motionless. The catheter lay on a sterile tray near Dr. Chen’s elbow, its refined casing pale grey under the procedure lights. Linnea had sent the final engineering sign-off at two in the morning, fifty-seven days after the council had stopped the rushed test at Nangang. The adhesion results were above ninety-three percent on all three validation samples. The documentation was complete. I had checked it twice before I left the office.

None of that made the room feel safe.

“Chloe.” Dr. Chen’s voice came without turning. “You have the bench validation summary?”

“Yes.” I pulled the folder from my bag and held it up. “Linnea’s casing passed all three adhesion checks. The impedance calibration was confirmed at ten millimetres per second. The barrier is stable.”

He turned then, one hand resting on the monitor console. “And the compassionate-use authorization?”

“Signed by the hospital review board this morning. I have the confirmation.”

He nodded once, a small precise motion, and turned back to the screen. The patient was a sixty-four-year-old man with a calcified occlusion in the left anterior descending artery, too fragile for open surgery and too advanced for the standard wire-guided approach. His daughter had signed the consent form at seven-fifteen, her handwriting cramped and careful in the box marked I understand this is an experimental procedure.

“Begin insertion,” Dr. Chen said.

The clinical team moved around the table with the quiet economy of people who had done this many times before. I watched the imaging screen as the catheter entered the femoral artery, a thin grey line inching upward through the vascular map. The impedance readings flickered on a second monitor to the left, numbers I had learned to read over the past eight weeks of documentation review: tissue resistance, flow velocity, tip position in three planes.

I wrote the time in the procedure record. 14:17.

“Approaching the LAD,” the attending fellow said. His hand hovered over the guide controls. “I’m seeing resistance on the distal end.”

Dr. Chen stepped closer to the imaging screen. “Hold position.”

The impedance numbers jumped. I saw it before anyone spoke: the tissue resistance reading had climbed from twelve hundred to just over two thousand ohms in the space of three seconds, and the flow velocity had dropped to near zero. The catheter tip was pressing against something that was not supposed to be there.

“Calcified cap,” Dr. Chen said. His tone did not change. “More extensive than the angiogram suggested.”

The fellow’s hand withdrew from the guide controls. “Do we abort?”

I looked at the procedure record, the blank line where the outcome notation would go. The catheter’s casing was stable at ninety-three percent adhesion. The impedance guidance was designed for exactly this kind of obstruction: real-time tissue mapping that could distinguish between soft plaque and calcified blockage, between vessel wall and something that should not be opened with force. Linnea had spent six weeks refining the sensor array to give the operator that distinction.

But the man on the table was sixty-four years old and his daughter had written her name in cramped blue ink, and Kai and Wei had been standing at a test bench when the battery cell blew, and no amount of engineering sign-off could make those facts sit quietly together.

“The impedance is showing a circumferential calcification,” Dr. Chen said. He pointed at the screen without touching it, his finger tracing the outline of the obstruction. “The core is softer. We can navigate it if the guidance holds.” He looked at me. “Chloe, I need the calibration log for the sensor array. The most recent one.”

I turned the pages of the folder. My fingers felt thicker than they should have, slower. “Here. Calibrated this morning at zero-nine-hundred. Drift under half a percent.”

“Good.” He turned back to the fellow. “Activate the low-frequency impedance mapping. Slow advance, no more than two millimetres per second. I want the readings at every half-second interval.”

The fellow nodded. His hand returned to the guide controls, and the catheter tip resumed its advance on the screen, a grey line nudging against a white mass that looked solid and unforgiving. The impedance readings flickered, steadied, flickered again. The tissue resistance held at two thousand ohms, then dipped to eighteen hundred as the tip found the softer core.

I wrote the numbers down. My handwriting was less careful than the daughter’s had been.

“Passing the proximal edge,” the fellow said.

The catheter moved through the calcified cap in increments so small they barely registered on the screen. Half a millimetre, then another. The impedance guidance held steady, the sensor array mapping the boundary between hard plaque and vessel wall with a precision that made the fellow’s shoulders relax by a visible degree.

“Clear of the obstruction,” Dr. Chen said. “Confirm flow.”

The flow velocity number climbed. Eight hundred. Twelve hundred. Fifteen hundred and steady. The vitals monitor beeped its same low rhythm, and the patient’s blood pressure had risen by four points, and the nurse at the IV line let her hand drop from the drip control and rest at her side.

“Flow restored,” the fellow said. His voice had a tremor in it that he was working to control. “Impedance readings normalizing across all three planes.”

I wrote 14:31, obstruction cleared, flow restored, patient stable in the procedure record, and then I set the pen down on the stand and let my hand rest flat on the page. The paper was cool under my palm. The ink from the daughter’s signature had bled a little where she pressed too hard, and I noticed that I had been looking at it for several seconds without really seeing it.

“Chloe.”

Dr. Chen had stepped away from the monitor bank. He removed his glasses and cleaned them with a cloth from his coat pocket, a motion I had seen him perform a dozen times in the Neihu meeting room and the Nangang bay. But here, under the procedure lights, it looked less like a habit and more like a deliberate pause, a moment carved out for the weight of what had just happened to settle.

“The record is complete?” he asked.

“Yes.” I lifted my hand from the page. “Time stamps, calibration logs, impedance readings at half-second intervals. The casing validation is attached. Everything is documented.”

“Then we have something to show the review board.” He replaced his glasses. “One procedure, one patient stabilized. Evidence that can be examined.”

“Not a declaration that every danger is gone.”

He looked at me for a moment longer than was necessary. “No. It is not that.”

The clinical team began the withdrawal sequence, and I stepped back from the procedure stand to give them room. The catheter came out clean, its casing intact, and the nurse set it on a separate tray for post-procedure analysis. The patient’s vitals held steady. The fellow stripped off his gloves and stood with his hands braced on the edge of the equipment cart, his head bowed, breathing slowly.

I thought about Linnea, who had refused to certify the earlier casing and then spent fifty-seven days rebuilding it from the barrier up. I thought about Sean, who had signed the charter and then stayed in the Nangang bay until midnight for six weeks running, documenting every batch number and calibration cycle the council asked for. I thought about Kai’s marker, still tucked behind his ear when they found him, and Wei’s dented thermos rolling under the bench, and the fact that no successful procedure would make either of those objects disappear.

The catheter had cleared a blockage that would have killed a man within weeks. The evidence was specific and valuable. It did not erase the risks that had brought the work to this point, and it did not make the biometric band’s safety obligations any less urgent simply because the medical result felt more immediate.

I closed the procedure folder and tucked it under my arm. The nurse was adjusting the patient’s blanket, and the fellow had straightened up and was speaking to Dr. Chen in a low voice about the post-procedure monitoring protocol. The vitals monitor beeped on, steady and indifferent, and the afternoon light through the procedure room’s single high window had shifted from white to a pale amber that meant the day was moving toward evening.

I walked to the door and stopped with my hand on the frame. The signed record was solid under my arm, and the catheter lay on its tray with the casing still pale grey and unbroken, and the patient’s daughter was in a waiting room somewhere in the building with no idea yet that her father’s heart was beating steadily for the first time in months.

Dr. Chen looked up from the monitor. “The review board meets on the fifteenth.”

“I know.”

“Bring the record.”

“I will.”

I stepped into the corridor and let the door click shut behind me. The fluorescent lights hummed overhead, and somewhere down the hall a phone rang twice and stopped, and I started walking toward the elevator with the folder pressed against my side and the impedance readings still flickering behind my eyes, one number after another, each one written down and accounted for.

The Nangang lab sat low and grey against a sky that had been threatening rain since noon, and by the time I pulled into the lot the first drops were spotting the concrete in uneven clusters. The air through the open window tasted of ozone and wet asphalt, the kind of late-afternoon light that turned everything flat and colourless before the storm actually broke.

I had the charter in my bag, three pages on the same legal pad I had left on the meeting-room table Day 42 earlier, the paper now soft at the edges from being handled too many times. Sean’s name was still missing from the signature block. Linnea had not returned to the office. The board vote was tomorrow morning, and Horizon Apex’s frozen-funds notice still sat in my phone, unread for the fourth time since breakfast.

The development bay smelled of isopropyl alcohol and the faint chemical tang of curing epoxy, familiar enough now that I barely registered it. The testing benches ran the length of the far wall, and at the centre station the catheter prototype lay opened across a clean mat, its ceramic barrier exposed where the housing had been removed for inspection. A workstation monitor to the left displayed the adhesion results in columns, and even from the door I could see the red-highlighted cells where the numbers had fallen below threshold.

Sean stood at the bench with his arms crossed, his Stanford hoodie rumpled in a way that suggested he had been wearing it since the day before. He did not look up when I came in, but he said, “The barrier failed again.”

“I saw the results.” I set my bag on an empty stool and pulled out the legal pad. “Linnea sent them through this morning.”

“Then you know we are out of time.”

“I know the adhesion checks have been inconsistent for three runs.” I held the pad against my chest, the cardboard backing damp from the humidity. “I also know the board votes tomorrow, and if you are not here to run the company, Victor Chen’s term sheet goes with you.”

He turned then, and his face was drawn tighter than it had been in the office three days ago. The sleep deprivation had settled into something structural, the kind of exhaustion that stopped registering as tired and started looking like a permanent feature. “You brought the charter.”

“I said I would.”

I laid it on the bench beside the catheter, next to a tray of ceramic samples that had been labelled and set aside. The pen I had left on the meeting-room table was still tucked into the spiral binding, and I pulled it free and set it across the signature page.

Sean read the language again. I watched his eyes track across the halt-authority clause, the section that gave the safety council binding veto power over any test, any run, any procedure it deemed unsafe. The section Linnea had insisted on, the one that read no founder override in plain terms.

“This means I cannot order a test to proceed if the council says no.”

“That is what it says.”

“Even if the council is wrong.”

“The council is three people with the evidence in front of them. If they are wrong, the evidence will show it.” I kept my hands still at my sides. “And then you make your case, and they hear it, and the decision belongs to the group.”

He looked at the catheter on the bench. The ceramic barrier sat in its housing, the surface dull under the overhead lights, and the adhesion data on the monitor had not changed. The red cells were still red.

“If I sign this,” he said, “I am giving up the authority to move fast when moving fast is the only thing that keeps us alive.”

“You are sharing the authority to decide when moving fast is dangerous.” I pointed at the monitor. “That barrier has failed three adhesion checks. Linnea flagged it. The data is right there. If you could order a test tonight anyway, would you?”

He did not answer immediately. The rain had picked up outside, a steady drum against the low roof, and somewhere in the bay the ventilation cycled off with a soft mechanical click.

“Yes,” he said finally. “I would.”

“That is why the charter exists.”

He picked up the pen. His hand was steady, but he held it for a long moment without moving, the tip a quarter inch above the paper, and I thought about the Day 42 that had passed since I left this same pad on the meeting-room table, the refrigerator ticking into the quiet, the office waiting. He had spent those three days running the numbers on his spreadsheet, modelling a future that kept coming up short, and now the only number that mattered was the one signature he had been refusing to give.

He signed.

The stroke was quick and unhesitating, the way someone signs a document they have already decided to accept. He set the pen down beside the pad and stepped back from the bench, and I did not say anything for a moment because the signature was not the end of the work. It was the beginning of a different kind of work, the kind where authority had to be exercised before it meant anything.

“The barrier failure,” I said. “I am bringing it to the council.”

Sean’s expression did not change, but his hand went still on the edge of the bench. “We do not have a council yet.”

“We do now.” I pulled out my phone and sent the message to Linnea, a single line asking her to review the adhesion data and register her vote. Then I called Dr. Chen at the hospital, and when he answered I told him the charter was signed and the barrier had failed and the council needed to convene.

His voice came through the speaker thin and precise. “The adhesion threshold was set at ninety-two percent. What did the last run show?”

“Eighty-seven on two samples, eighty-four on the third.”

“Then the test does not proceed.” He said it without hesitation, the same clinical flatness he used when reading a patient’s chart. “Record the failure, document the variance, and do not run the barrier under load until the adhesion is understood.”

Linnea’s response arrived a minute later, shorter and sharper: No test. Barrier fails spec. We stop until root cause is found and recorded.

The council had voted. Two to zero, with Sean’s signature binding him to the outcome.

I looked at the catheter on the bench, the exposed barrier still waiting for a test that would not come tonight. The rain was heavier now, drumming against the roof in a steady rhythm, and the light through the high windows had gone from grey to something closer to charcoal. The liquidation warning was still active. The funds were still frozen. Tomorrow the board would vote, and Victor Chen would decide whether a company with a safety charter and a halted catheter run was worth saving.

Sean said, “What can we still salvage tonight?”

“The barrier documentation. The adhesion data needs a full analysis, and Linnea will want the batch numbers cross-referenced against the materials log.” I opened my bag and pulled out the biometric band, its green indicator dark, the casing cool in my palm. “And we need to allocate the remaining bench hours across both products. The band’s discharge tests are still pending, and the council’s authority covers consumer-line safety the same as the catheter.”

He looked at the band in my hand, and something in his face tightened, but he did not argue. The charter applied to all of it now, the medical device and the wearable and whatever else Aetheris built, and he had signed that into existence with the same pen that was still lying on the bench beside the legal pad.

“Fine,” he said. “Document the failure. Cross-reference the batches. Schedule the band tests.” He turned back to the monitor, and the red-highlighted cells were still there, still below threshold, still telling us what we already knew. “And tell Linnea I want the root-cause analysis by end of week.”

“I will tell her the council requests it.”

He did not turn around. The rain kept falling, and I packed the signed charter back into my bag and left the catheter lying open on the bench, its ceramic barrier inert and unproven, its next test waiting on an answer that had not arrived yet.

The office door swung inward on a hinge that needed oil, and the sound of it cut across the open floor louder than I’d meant. Eight days since the memorial. Eight days of frozen accounts and a phone that stayed silent no matter how many times I checked it, and the first thing I noticed was the quiet.

Not the ordinary quiet of a morning before everyone arrived. A different register entirely. Four workstations near the windows had been stripped to bare desks, their monitors gone, their chairs pushed in with a finality that read as permanent. Ruoxi’s old terminal sat dark. The firmware team’s three machines were unplugged and stacked beside the wall, cables coiled neatly on top, the kind of care someone takes when they know they won’t be coming back.

My notebook was in my bag. I didn’t reach for it. The list of names I kept on the inside cover had been accurate eight days ago, and now it wasn’t, and writing a new one wouldn’t change the empty chairs.

Sean was at his workstation near the meeting room, his back to the door. He had a spreadsheet open and a cup of something that had stopped steaming an hour ago. His hoodie was the same Stanford one he’d worn to the memorial, and his hair looked like he’d been running his hands through it instead of sleeping.

“The advisory board is voting on your termination,” I said.

He didn’t turn around. “I know.”

“Victor’s office sent a message this morning. They won’t wait past the vote to decide whether the frozen funds stay frozen.” I set my bag on the nearest workstation and pulled out my phone. The message was still open on the screen, three lines from Horizon Apex’s legal counsel that I’d read four times on the train from the station. “If the board removes you, the Series B evaporates. If they don’t, we still have to explain to a prosecutor why the company that couldn’t meet payroll made the decisions it made.”

Sean turned then. His face was thinner than it had been eight days ago, the hollows under his eyes darker, but his voice came out the same as it always did. Clipped. Directive. “We need a recovery schedule. Catheter validation, materials documentation, the data package the review board asked for. Assemble it by end of week.”

I stayed standing.

“Who covers the safety review before I accept that assignment?”

“What?”

“You’re asking me to build a schedule for work that killed two people. I want to know who signs off on the safety review before anyone touches a bench.”

He looked at me the way he looked at a test result that didn’t match his model. “Chloe, the company is running out of time.”

“The company ran out of time the night Kai and Wei died. What we’re doing now is deciding whether we rebuild the same way we built before, or whether we change who gets to say stop.”

The air conditioning cycled on above us, a low rattle that filled the space where his answer should have been. I waited. The spreadsheet on his screen scrolled automatically, some background macro still running, and the numbers shifted in their columns without anyone watching them.

“You think I don’t know what my decisions cost,” he said.

“I think you know. I don’t think you’ve told anyone else what you knew when you made them.” I pulled out the chair at the workstation beside me and sat down, not across from him but not beside him either, an angle that put the meeting room table between us. “The battery cells came from Shenzhen. You ordered them without verification. You bypassed the pressure regulator on the catheter setup to save forty minutes per calibration run. None of that went through a stop review. None of it was shared with Linnea or Dr. Chen or me until after the fact.”

“The catheter data deadline was Friday.”

“And Kai Huang is dead.”

The sentence landed and stayed. Sean’s hand moved toward his coffee cup and stopped short, and for a long moment he didn’t speak. The rattle from the air conditioning filled the office again, a sound I’d heard a thousand times and never really registered until now.

“I’m not saying your urgency caused every failure,” I said. “I’m saying the company can’t ask workers to carry the consequences while founders keep their authority unquestioned. That’s not a staffing problem. That’s a structure problem.”

“And what structure do you want instead?”

I opened my mouth to answer, and the office door swung open again before I could.

Linnea Tsai stepped inside with a binder under one arm and her safety glasses pushed up onto her close-cropped hair. She was wearing a pressed shirt with the sleeves rolled to her elbows, and she looked at the empty workstations once before her gaze settled on Sean. She didn’t offer a greeting.

“I brought the battery dossier,” she said. “Everything the team could verify about the cells and the testing conditions before the explosion. What we know, what we don’t, and what we should have asked before anyone ran a discharge test.”

Sean straightened. “You resigned.”

“I did. I’m not un-resigning.” She set the binder on the meeting room table and flipped it open. The pages inside were dense with tables and annotations, handwritten corrections in the margins, dates and batch numbers and a timeline that ran backward from the night of the test to the afternoon the cells arrived from Shenzhen. “I’ll help rebuild if the conditions are right. Not before.”

“What conditions?” I asked.

Linnea turned to me. Her voice was flat, declarative, the same register she used to describe polymer off-gassing or actuator discoloration. “Safety protections that give the people doing the work real authority to halt it. Not a policy in a drawer. Not a bench-hour limit that gets ignored when the deadline gets tight. A binding mechanism that means if I say stop, the work stops, and no one can override that because they’re in a hurry.”

Sean’s jaw tightened. “Linnea, the catheter work has no credible path without your expertise. You know that.”

“Then you know what it costs to say no to me.”

The three of us stood at three points of the open floor, the binder between us on the table like an exhibit no one wanted to be the first to touch. I thought about the frozen-funds notice in my pocket, the investigator’s card still tucked behind it. I thought about the biometric band’s green light pulsing on my desk for six months, a consumer promise that had always run parallel to the catheter work and never quite touched it, as if the risks of one product line belonged to a different company than the other.

“The consumer band doesn’t get a separate standard,” I said.

Sean looked at me.

“The catheter and the band compete for the same money, the same bench time, the same people. If we’re building safety obligations into how this company operates, they apply to both. Scarcity isn’t an exemption.”

“The band is shelved,” Sean said. “Victor’s term sheet was clear.”

“Victor’s term sheet requires us to preserve both for a dual listing. He told me that himself, the night of the inspection.” I said it without emphasis, the same way I’d said everything else, and I watched Sean register that I’d known something he hadn’t for fifteen days. He didn’t ask why I hadn’t told him. Maybe he understood. Maybe he was just too tired to fight two battles at once.

Linnea pulled a pen from the binder’s spine and set it on top of the dossier. “I want it in writing. A charter that defines who can stop work, under what conditions, and what happens when someone tries to override a halt. Signed by the CEO. Filed with the board.”

“That’s a governance document,” Sean said. “That takes weeks.”

“Then start now.”

I walked to the meeting room and pulled a legal pad from the supply cabinet. The paper was clean and unlined, the kind we used for whiteboard notes and investor presentations, and I set it on the table beside Linnea’s binder. My pen was in my bag. I retrieved it, a battered ballpoint I’d carried since the first animal trial, and wrote Safety Charter across the top of the first page in letters large enough to fill the room.

“Section one,” I said. “Halt authority. Any engineer or technician who identifies a safety risk has the right to stop work immediately, without prior approval, and the stop remains in effect until a review committee clears it.”

“Review committee,” Sean repeated. “Who sits on it?”

“Linnea. Dr. Chen. You. Me. The person who called the halt. No decision without a majority, and the person who called the halt has a vote.”

Linnea pulled out a chair and sat down across from me. “Section two. No founder override. The CEO cannot unilaterally resume work that has been halted under section one.”

“That’s my authority you’re writing out of existence.”

“It’s your authority that killed two technicians.” She didn’t look up from the page. “You bypassed a safety valve with a piece of tubing because you wanted faster calibration data. I’m not giving you the chance to do it again.”

The air conditioning cycled off. In the sudden drop in sound, I could hear the faint tick of the kitchenette refrigerator, a metronome I’d stopped noticing months ago. Sean stood with his hands at his sides, and I watched him weigh the choice Linnea had just put in front of him. Without her, the catheter work had no path. With her, he had to sign away the speed he’d always treated as his best tool.

“The biometric band stays in the charter’s scope,” I said. “Same halt rules. Same review process. If we’re building a standard, it covers everything we build.”

“The band isn’t active.”

“It was active enough to kill someone.”

I wrote the clause in before he could answer. The pen scratched against the paper, and the sound of it was the only thing in the room for a long moment. Linnea turned a page in her dossier and read me a batch number from the Shenzhen shipment, and I added it to the section on verification requirements. She read me the timeline of the discharge test, the moment the cells overheated, the gap between the first warning and the explosion, and I wrote each data point into the charter as a condition that could never be repeated.

Sean watched us work. He didn’t sit down. He didn’t pick up the pen Linnea had set on the table. But he didn’t leave, either, and that was the first thing he’d done in eight days that looked like a decision.

The draft filled three pages by the time I stopped writing. It wasn’t finished. It needed legal review and board review and language precise enough to survive a prosecutor’s questions. But the shape of it was there on the meeting room table, a document that said what we would not do again and who would have the power to stop it, and Linnea’s signature condition sat in section two in handwriting that was mine.

“I need Sean’s signature before I come back,” Linnea said. She stood and closed her binder, leaving the pen where it lay. “I’ll be at the Nangang lab if you need the rest of the dossier. The bay still has my notes from the actuator analysis.”

She walked out the same way she’d walked in, without a goodbye, and the door swung shut behind her on the hinge that still needed oil.

I pushed the legal pad across the table toward Sean. Three pages of clauses and conditions and the names of two dead technicians written into the preamble. He looked at it the way he’d looked at the frozen-funds notice eight days ago, a document that demanded an answer he didn’t have yet.

“The board votes in seventy-two hours,” I said. “If you sign this before they meet, it changes what they’re voting on. They won’t be deciding whether to fire a founder. They’ll be deciding whether to adopt a safety charter that gives workers halt authority, or to reject it and explain why.”

“And if I don’t sign?”

“Then Linnea doesn’t come back. The catheter stays dead. And the board votes on your termination with nothing else on the table.”

Sean picked up the pen. He held it for a moment, the weight of it balanced between his fingers, and then he set it back down beside the legal pad without uncapping it.

“Seventy-two hours,” he said.

He walked back to his workstation and sat down in front of the spreadsheet, and the macro was still running, the numbers still shifting in their columns, a model that kept calculating a future that might not exist. I left the charter on the table with the pen beside it and walked to the kitchenette to make a fresh pot of coffee, and the refrigerator ticked once into the quiet and then stopped, and the office waited for a signature that would tell us whether authority could actually be shared.

The memorial hall smelled of lilies and steamed rice, the lilies too sweet and the rice faintly scorched from the kitchen at the back of the venue. I noticed the scorched note before I noticed anything else, because it was easier to notice than the photographs on the altar table. Two faces I had last seen in the red wash of emergency lights, now framed in black and set beside white flowers and bowls of fruit the families had brought.

Sean stood beside me with his hands in his pockets. He had not spoken since we left the car.

The hall was a rented space in eastern Taipei, a long room with folding chairs arranged in rows and a low platform at the front where the altar had been set. Maybe sixty people had come. I recognized most of them. Linnea was near the back, her coat still buttoned, her face turned toward the floor. Dr. Chen stood with his hands clasped in front of him, his narrow glasses catching the overhead light each time he inclined his head toward someone who spoke to him. The remaining engineering staff had gathered in a tight cluster near the side door, the way people do when they are not sure they belong at the front of the room.

A woman I did not know approached me before I had taken three steps past the entrance. She was maybe fifty, with grey threaded through hair she had pinned back carefully, and she wore a dark blouse that looked new and uncomfortable.

“You are Chloe Yeh.”

It was not a question. I nodded.

“I am Kai’s mother.” She did not offer her name. “I want to know how my son was allowed to run a test at night with batteries no one had checked.”

Behind her, a man I took to be Kai’s father had stopped halfway to the altar and turned to watch us. His face was still, the kind of still that takes effort.

I did not reach for my notebook. I had left it in the car, because I had known, driving here, that no staffing chart and no compliance list would answer what the families needed to ask. I made myself meet her eyes.

“The batteries came from a supplier Sean had used before. They were not verified for that test. I knew that, and I did not stop it.”

She stared at me. Her mouth tightened, and for a long moment she said nothing, and then she nodded once and walked back to her husband. He took her hand. They did not look at me again.

Sean had heard. He had not moved. His jaw was set, and he was looking at the altar photographs with an expression I could not read, or did not want to.

Wei’s parents found us ten minutes later. His mother was shorter than I had expected, and she carried a small cloth bag that she kept shifting from one hand to the other. His father wore a jacket with a polytechnic emblem on the pocket, and he spoke first.

“Wei called us every Thursday.” His voice was quiet and careful, the same way Wei’s had been. “Last Thursday he said the company was pushing to finish before the end of the month. He said he was not sure all the parts had been checked.”

I heard Sean inhale beside me.

“He was right,” I said. “They had not been checked. The cells were unverified, and the test should not have gone forward.”

Wei’s mother stopped shifting the bag. “Then why did it?”

I had no answer that would make the question smaller. I told her the truth I had, which was that the schedule had been compressed, and that the pressure to deliver data had overtaken the verification steps Wei had wanted, and that I had seen the risk and said nothing that would have stopped the work.

She looked at me for a long time. Then she turned to Sean.

“You were his boss.”

Sean opened his mouth. Closed it. “I ordered the test,” he said, and his voice was flat in a way I had never heard from him before, not clipped or directive, just emptied out. “The cells were my decision.”

Wei’s father put his hand on his wife’s arm. They walked back to the front row without another word.

I stood beside Sean and watched the families take their seats. The rice scorch had faded, or I had stopped noticing it. A monk began to chant near the altar, the syllables low and rhythmic, and I let the sound fill the space where more words would have been useless.

Linnea found me near the refreshment table, where someone had set out trays of sliced fruit and a pot of tea that had gone lukewarm. She did not take any food. She stood with her arms crossed and looked at the table as if she could not remember why she had walked over.

“I’m leaving,” she said.

I had expected it. That did not make it land more softly.

“When?”

“Today. After this.” She kept her voice low, but it did not waver. “I can’t go back to the bay. I can’t look at the actuator housing and pretend I’m solving a materials problem when the problem is that we let two people die so we could save a week of testing.”

I wanted to tell her that the company needed her. That she was the only one who understood the polymer degradation data, that without her the catheter work would stall, that her leaving would make everything harder. All of it was true, and none of it was a reason she should stay.

“I understand,” I said.

She looked at me then, and something in her face shifted. “Do you?”

“I’m not going to ask you to stay.”

She nodded. She did not say goodbye. She walked toward the side door, and two of the engineers from the cluster followed her out. A third left a minute later, and then a fourth, and I stood by the table with the lukewarm tea and watched the team I had tried to hold together walk out into the afternoon.

A man in a dark suit approached me after the chanting stopped. He was not one of the mourners. He carried a slim leather folder, and he introduced himself as an investigator with the district prosecutor’s office, and he asked if I was Chloe Yeh.

“I need to inform you that the office has opened a manslaughter inquiry into the events at the Nangang Development Laboratory on the night of the explosion.” He spoke without inflection, the words practiced. “You may be contacted for questioning. You have the right to legal representation.”

I took the card he offered. My hand was steady. I did not know why it was steady.

“Thank you,” I said, because I could not think of anything else.

He nodded and walked away, and I put the card in my pocket without looking at it.

Sean was still near the altar. He had not sat down. He was staring at Kai’s photograph, and his hands had not come out of his pockets, and I did not go to him. There was nothing I could say that would make him the person the families had needed him to be.

My phone buzzed. A message from Horizon Apex, routed through their legal counsel: Pending the outcome of the criminal investigation, all disbursements under the Series B term sheet are frozen effective immediately. No further drawdowns will be processed until the inquiry is concluded.

I read it twice. The tea had gone cold. The fruit was untouched. The hall was emptying, the folding chairs scraping against the floor as people stood and gathered their things and walked toward the doors, and I stood at the refreshment table with the frozen-funds notice on my screen and the investigator’s card in my pocket and the taste of scorched rice still at the back of my throat.

Sean looked at me from across the room. I held up the phone, and he read the message on my face before he crossed the distance to read it on the screen. He took the phone from my hand and stared at the words, and his mouth moved slightly, the way it did when he was running a calculation that would not resolve.

“The company doesn’t have enough to make payroll past the end of the month,” I said.

He handed the phone back. “I know.”

I waited for him to say something else. A deadline. A directive. A technical shorthand that would turn the problem into something solvable. He did not. He stood beside me and watched the last of the mourners leave, and the monk began to gather the offerings from the altar, and the afternoon light through the high windows turned grey and thin.

I folded the frozen-funds notice and tucked it into my pocket beside the investigator’s card, and I walked out of the memorial hall with the weight of both against my hip.

Fifteen days had not been enough to change the air in Nangang. The same solvent smell clung to the corridor walls, and the same fluorescent panels buzzed overhead, one of them still flickering at the far end near the storage room. I had come back at ten at night because the overnight work had piled up past what the day shift could absorb, and because Sean had stopped asking whether I could be there.

I let myself into the development bay and found the lights already on. Sean stood at the catheter test setup, his back to me, one hand on the pressure regulator. The actuator housing sat open on the bench beside him, its discoloration from the earlier heat spike still visible under the work light. He had not heard me come in.

“You’re early,” I said.

He didn’t turn. “The audit data needs to be clean by morning. The review board reconvenes next week and Victor wants the catheter package before that.”

“Victor wants the package before the review board meets. That’s not the same thing.”

Now he looked at me. His Stanford hoodie had a fresh stain on the sleeve, something dark that could have been coffee or solvent. “It’s the same thing if the review board won’t look at it without the investor’s confidence. You know that.”

I set my notebook on the nearest empty surface and walked over to the bench. The regulator was a standard model, the kind that limited flow to the test chamber during calibration runs. I could see where the bypass had been fitted, a short length of tubing that routed around the safety valve entirely. It was not hidden. Sean had not tried to hide it.

“What does that do?” I asked, though I could already see.

“Cuts the calibration cycle by forty minutes per run. We need six runs tonight.” He tapped the tablet beside him. “The valve tripped twice last week on false positives. The sensor threshold is set too conservatively. I checked it.”

“You checked it against what?”

“The manufacturer’s spec sheet.”

I did not ask which manufacturer. The cells for the consumer line had come from Shenzhen two days ago, packed in foam that still smelled of the factory, and Sean had signed for them himself. I had seen the invoice on his desk that morning, a single page with a company name I did not recognize and a unit price that was forty percent below the quote from our regular supplier.

“The consumer line test is still scheduled for tonight,” I said. “Those batteries haven’t been through verification.”

“They’re standard cells. The band draws less than half an amp.” He turned back to the regulator. “Linnea can run the materials analysis on the actuator next week. Right now I need the audit data.”

I opened my notebook to the page where I had written the stop criteria I had promised Linnea and Dr. Chen after the last session. The list was short. I had meant to circulate it, to get signatures, to make it binding. Fifteen days of rebuilding the catheter documentation under the stop-order’s constraints, and I had not done it.

“Sean, we agreed on written stop criteria before the next test.”

“And we’ll have them. After tonight’s data is in.” He said it without looking up, the same tone he used for delivery schedules and supplier lead times. A problem already solved because he had decided it was solved.

My phone buzzed in my pocket. I stepped away from the bench to check it. Victor Chen’s name on the screen, and a single line: Call when you can. Not urgent but time-sensitive.

I walked to the far end of the bay, past the workstations where Kai and Wei would be setting up later, and dialed.

Victor answered on the second ring. “Chloe. Thank you for calling back.”

“It’s late. What do you need?”

“I’ve been reviewing the progress reports Sean sent over. The catheter rebuild is on track, which is good. But I want to make sure you understand the full picture.”

I leaned against the wall, the concrete cool through my shirt. “The full picture being the term sheet you sent three weeks ago.”

“The term sheet reflects the immediate condition. What I need you to know is that Horizon Apex’s actual mandate for this Series B expects Aetheris to preserve both products. The catheter and the biometric band. The dual listing is central to our valuation model.”

I looked across the bay at Sean, still bent over the regulator. He had not heard any of this. Victor had called me, not him.

“Victor, the band’s development has been running on a skeleton crew since the stop-order. We lost four people. We’re running overnight tests with cells that haven’t been through verification because there wasn’t time to source from the regular supplier.”

“I’m not asking for a timeline on the band tonight. I’m telling you what the mandate requires so that you can plan for it. Sean has been focused on the catheter, which is understandable. But the band cannot be allowed to stall.”

I wanted to ask him why he was telling me this instead of Sean. I did not ask, because I already knew the answer. Victor had watched Sean push back against every constraint the stop-order imposed, and he had decided that the operations lead was the safer channel for a message that required patience.

“I understand,” I said.

“Good. I’ll send the revised milestones by morning.” The line went quiet for a moment. “Chloe. This stays between us until I have Sean’s buy-in on the catheter data. I need you to hold it.”

I ended the call and stood there with the phone in my hand, the screen still warm. The bay hummed around me, the ventilation running at low speed, the work lights casting hard shadows across the floor. Sean had moved on from the regulator and was now calibrating the pressure sensor, his movements quick and certain.

I did not tell him what Victor had said.

The auditor arrived at eleven. I was at the logistics station, updating the test schedule to reflect the overnight runs, when I heard the bay door open and a voice I did not recognize ask for the person in charge.

He was a short man in a dark jacket, carrying a tablet and a laminated badge from the TFDA’s compliance division. He introduced himself as Inspector Lin and handed me a notice of unannounced inspection, the paper still warm from a portable printer.

“We’re conducting a spot check on bench conditions and documentation,” he said. “This is a standard procedure during an active stop-order. I’ll need access to the full bay.”

Sean looked up from the catheter setup. His face went very still, the way it did when a supplier called with bad news and he was calculating how much it would cost him.

“Of course,” I said. “I’ll walk you through.”

I led him past the testing benches, the storage racks, the calibration station. He checked each workstation against a list on his tablet, pausing to photograph serial numbers and inspect cable routing. His manner was polite and thorough, the kind of thoroughness that came from doing this a long time and knowing what people tried to hide.

We reached the third bench from the wall, the one nearest the storage room, and he stopped.

“This bench has structural damage,” he said. He crouched and ran a finger along the underside of the work surface. “The support bracket is cracked. When was this reported?”

I looked at the crack. I had seen it before, three weeks ago, during another inspection, the one that had preceded the stop-order. I had covered it with a clamp and a note to order a replacement, and then the stop-order had come and the departures had started and I had never placed the order. The clamp was still there, hidden by the equipment stacked on top.

“I don’t have a record of a report,” I said. My voice came out flat and even, the way it did when I was holding something in.

“I’ll need to note that.” He made an entry on his tablet. “Damaged equipment that hasn’t been logged is a compliance issue. It will need to be addressed before the stop-order can be lifted.”

Sean had walked over while the inspector was crouched. He looked at the bench, then at me, and I saw him register the clamp, the position of the equipment, the way I had not answered the question directly. He said nothing. The inspector moved on to the next station, and Sean followed him, and I stood there with the crack and the clamp and the weight of everything I had not told anyone.

Kai and Wei arrived at midnight. Kai had his lab coat on before he was through the door, the marker already behind his ear. Wei carried his labeled binder under one arm and a thermos in the other hand.

“Evening, Chloe,” Kai said. “Sean said we’re running six catheter calibrations and the band discharge test. Is that right?”

“That’s what’s scheduled.”

Wei set his binder on the workstation and opened it to a fresh log page. “The cells for the band test. Have the verification results come back yet?”

I looked at Sean, who was still at the catheter setup. He did not turn around.

“They’re standard cells,” I said. The words tasted wrong in my mouth, a borrowed answer I had not chosen.

Wei hesitated, his pen poised above the log. “Standard cells still need a verification run before a discharge test. That’s the protocol.”

“I know the protocol.”

He looked at me for a moment longer, then wrote something in the log. I did not ask what. I should have stopped the test right then. I should have called Linnea and asked her to come in and verify the cells herself. I should have told Sean that the overnight work could not proceed until the batteries had been through the same scrutiny we were demanding for the catheter.

I did not do any of those things. I went back to the logistics station and updated the schedule to reflect the inspector’s findings, and I told myself that the band test was low-risk, that the cells were standard, that Sean had checked the spec sheet. I told myself the same things I had been telling myself for thirty-five days, and I made them sound reasonable because I needed them to be.

Kai set up the band test at the far end of the bay, near the storage room. Wei ran the preliminary checks, calling out voltages and current draws while Kai noted them in the log. The band itself sat on the testing cradle, its green pulse steady, the same light I had seen on the first morning I unlocked the office in Neihu. The founding promise, still blinking, still waiting to be kept.

I was at the logistics station when it happened. The sound was not loud. A sharp crack, like a transformer blowing, and then a deeper sound that I felt in my chest before I understood what it was. The lights flickered and went out, and the emergency panels kicked in, washing the bay in red.

Smoke was already pouring from the far end of the bay. Thick, chemical, the kind of smoke that meant burning plastic and worse. I ran toward it, past the toppled equipment, past the calibration station where Sean was already shouting something I could not hear over the alarm that had started shrieking.

The band test station was gone. The bench had buckled inward, the cradle blown apart, and the band itself was a blackened smear on the floor. Kai lay face-down near the storage room door, his lab coat singed, the marker still tucked behind his ear. Wei was slumped against the wall, his binder open beside him, the log page half-filled and curling at the edges from the heat.

I knelt beside Kai and turned him over. His face was untouched, his eyes half-open, and for one impossible second I thought he was going to blink and ask me if he had understood the instruction correctly. He did not blink. I pressed my fingers to his wrist and felt nothing, no pulse, no warmth except the heat still radiating from the ruined bench.

Sean was at my side. He had his phone out, already dialing emergency services, but his hand was shaking so badly he had to try twice. I heard him give the address, heard him say the words “explosion” and “two down,” heard the dispatcher’s voice crackling back through the speaker.

I stayed on the floor beside Kai. The smoke was thinning now, pulled out by the ventilation, and the alarm had settled into a steady rhythm that matched the pounding in my ears. Wei’s thermos had rolled under the next bench and come to rest against a cabinet, still intact, the metal dented but unbroken. I stared at it for a long time, at the small ordinary object that had survived when the people had not.

The emergency crews arrived in twelve minutes. They moved through the bay with the efficiency of people who had done this before, checking vitals, photographing the scene, stringing yellow tape across the far end of the room. A paramedic knelt beside me and asked if I was hurt. I shook my head. She asked again, and I realized I had not spoken.

“I’m not hurt,” I said. My voice sounded like someone else’s.

Sean stood near the door, answering questions from a fire investigator. His face was grey, the kind of grey that had nothing to do with the light. He did not look at me. He did not look at the bodies.

At some point someone put a blanket around my shoulders. I did not remember who. I was still holding my notebook, the pages smeared with soot, the stop criteria I had never enforced still legible beneath the grime.

A woman in a TFDA jacket approached me and said something about a follow-up investigation, about preserving the scene, about notifying the families. I nodded. She asked if there was someone I needed to call.

Linnea, I thought. Dr. Chen. Victor. The names lined up in my head like items on a checklist, each one a call I did not know how to make.

“The families,” I said. “Kai and Wei. Someone needs to call their families.”

“We’ll handle that,” she said. “But there will be a memorial. The company will need to make arrangements.”

The company. I looked across the bay at Sean, still answering questions, still not meeting my eyes. The bypass was still fitted to the regulator. The cells that had killed two people had been ordered from a supplier whose name I did not know, at a price that had seemed like a saving. And Victor Chen’s mandate sat in my phone, the demand that both products survive, the pressure that had pushed every decision faster and harder until there was no room left to stop.

I pulled the blanket tighter and watched the emergency crews work. The red light from the panels washed over everything, the ruined bench, the scattered logs, the dented thermos still lying where it had rolled. Tomorrow I would have to call the memorial venue. I would have to write something for the families. I would have to sit across from Sean and ask him what he had been thinking when he fitted that bypass, and I would have to tell him what Victor had told me, and none of it would bring Kai and Wei back.

The paramedic returned and asked if I wanted to sit down. I was already sitting. I had been sitting on the floor of the development bay for twenty minutes, my notebook in my lap, the blanket slipping off one shoulder, and I could not remember standing up.

“I’m fine,” I said. “I just need a minute.”

She left me there. The investigator was taking photographs of the bypass now, the camera flash cutting through the red gloom in brief white bursts. Sean had finally stopped talking. He stood with his back against the wall, his hands at his sides, his face turned toward the ruined test station as if he were trying to solve a problem whose variables he could no longer name.

I looked down at my notebook. The stop criteria were still there, the words I had written fifteen days ago and never made real. I closed the cover and pressed my palm flat against it, the soot transferring to my skin, and I stayed like that until someone told me it was time to go.

The Nangang lab sat in a district of Taipei that still smelled like industrial solvents and river silt, a low concrete building wedged between a semiconductor packaging plant and a warehouse that changed tenants every six months. I hadn’t been here since the stop-order came down. Fifteen days of emails, of Sean asking when we could restart and me answering with the same paragraph from the TFDA letter. Fifteen days of watching the depleted team try to look busy while the catheter sat in its storage case and the biometric band’s green pulse kept blinking on my desk in Neihu, a promise nobody had officially withdrawn.

The development bay was cold. The ventilation ran at full draw, pulling air through the ceiling ducts with a steady low rush that made everyone speak a little louder than they needed to. Linnea had already set up at the testing bench when I arrived, her safety glasses pushed up into her close-cropped hair, a tablet open to the sensor logs beside her left elbow. Dr. Chen stood near the back wall, reading through a stack of printouts I’d sent over the night before. He hadn’t taken off his coat.

“The stop-order doesn’t permit clinical work,” I said. I set my notebook on the edge of the bench, open to a fresh page. “What we’re doing here is examining the device and the process. Nothing more.”

Linnea didn’t look up from the tablet. “Then why is Sean texting me about a timeline?”

“Because Sean texts everyone about timelines.”

She made a small sound that wasn’t quite agreement and tapped the screen. The actuator logs came up, a cascade of numbers I’d learned to read over the past year but still didn’t trust myself to interpret without her.

Dr. Chen set the printouts down on the bench beside my notebook. His glasses were the narrow rectangular kind that went out of fashion a decade ago, and they made him look older than fifty-two. “I have a question before we proceed.”

I nodded.

“Which of these readings are reproducible, and which are assumptions the validation team carried forward from the earlier bench runs?”

Linnea answered before I could. “The pressure curves are reproducible. We ran them six times before the stop-order, same setup, same results. The thermal data is less clean.” She swiped to another screen. “Actuator temperatures drift between runs. Not a lot, but enough that I wouldn’t call it stable.”

“Show me,” Dr. Chen said.

She turned the tablet so he could see. He leaned in, one hand on the bench edge, and read the columns without speaking. The ventilation cycled, a brief drop in the background rush, then picked up again.

“These spikes,” he said. “Here and here. They recur at the same point in the cycle.”

“I know,” Linnea said.

“And you’ve ruled out sensor error?”

“I ruled out the obvious sources. I haven’t opened the actuator housing yet.”

Dr. Chen straightened and looked at me. “If the thermal data isn’t stable, the safety review won’t accept the bench validation. The board will ask the same question I just did, and they won’t take a partial answer.”

I wrote thermal drift, not ruled out in my notebook. The pen left a small smudge where my palm rested on the page. “Then we document what’s reproducible and flag what isn’t. That’s why you’re both here.”

“And Sean?” Linnea asked.

“Sean wants the catheter data package ready by the Friday deadline.” I said it without inflection, the same way I’d said it in the meeting room two weeks ago. “He knows the clinical investigation is stopped. He still wants the technical work to move.”

Linnea’s jaw tightened, but she didn’t say anything. She pulled her safety glasses down over her eyes and turned back to the bench.

I watched her hands move across the equipment, checking connections, adjusting the sensor array. She worked the way I’d seen her work a dozen times before: quick, precise, no wasted motion. The small burn mark on her left glove was still there, a brown scorch the size of a fingertip from some earlier run she’d never bothered to explain.

“Start the next run,” I said. “We’ll watch the thermals.”

The catheter lay in its testing cradle, a slender polymer tube no thicker than a strand of spaghetti, the optical fibers catching the overhead light. Linnea keyed the sequence. The actuator engaged with a faint click, and the numbers began scrolling across her tablet.

For the first two minutes, everything held steady. Pressure curves matched the earlier runs. The optical sensors registered within expected range. I copied the initial readings into my notebook, the scratch of the pen loud in the quiet bay.

Then the temperature trace jumped.

Linnea’s hand stopped over the tablet. “There. Same spike, same point in the cycle.”

I looked at the screen. The number had climbed three degrees in under four seconds, then dropped back almost as fast. “Is that within tolerance?”

“It’s within the manufacturer’s spec for the actuator. But it shouldn’t be happening at all. The housing is supposed to dissipate that kind of load.”

Dr. Chen moved closer to the bench. “And if it doesn’t?”

“Then something is generating more heat than the housing can handle, or the housing material is degrading faster than we modeled.”

I wrote actuator heat spike, 3°C in 4 sec, housing dissipation insufficient and underlined it twice. The pen left a groove in the paper.

The smell came a few seconds later.

It was sharp and chemical, not the familiar ozone of electronics under load but something acrid that caught at the back of the throat. Linnea smelled it first. Her head came up, and she turned toward the testing cradle with an expression I hadn’t seen on her before.

“Stop the run,” she said.

I looked at the tablet. The numbers were still scrolling. “The pressure curves are still within range.”

“I don’t care about the pressure curves. That’s polymer off-gassing. Something is overheating.”

She reached past me and hit the kill switch herself. The actuator whined down, and the data stream stopped. The silence that followed was broken only by the ventilation, still pulling air through the ducts, still not fast enough to clear the smell.

Dr. Chen stepped back from the bench. “She’s right. That odor shouldn’t be present in a closed system. If the polymer is breaking down under thermal load, you have a materials problem, not a calibration problem.”

Linnea was already reaching for the housing release. “I need to see the actuator.”

I put my hand on the bench edge, not stopping her, just grounding myself against the cold metal. “Document it first. Temperature at shutdown, duration of the spike, when the odor became perceptible.”

“I know how to document a fault.” Her voice was flat, but her hands were steady on the release mechanism. “What I don’t know is who decided this run was safe to start without a thermal cutoff.”

Nobody answered. The question hung in the air with the chemical smell, and I wrote odor, polymer off-gassing, source unknown in my notebook because writing it down was the only thing I could do right now that didn’t require deciding who was at fault.

The bay door opened. Sean walked in, his tablet in one hand, his hoodie unzipped over a shirt that needed ironing. He looked at the stopped bench, at Linnea with her hands inside the housing, at Dr. Chen standing well back from the equipment.

“What happened?”

“Actuator heat spike,” I said. “Linnea caught it and stopped the run. There’s an odor we haven’t identified yet.”

Sean’s eyes moved to the testing cradle. “How long until you can restart?”

Linnea didn’t look up from the housing. “I’m not restarting until I know what caused the spike.”

“We don’t have time to chase every anomaly.”

“This isn’t an anomaly. It’s a pattern. I told you the thermal data wasn’t clean two weeks ago.”

Sean turned to me. “Chloe, we need this data package ready. Victor’s term sheet doesn’t pause because of a temperature reading.”

I looked at my notebook. The page was half full, most of it questions I couldn’t answer yet. “The run is stopped, Sean. Linnea made the call. I’m recording it.”

“Who authorized the stop?”

The question landed and sat there. Linnea’s hands stilled inside the housing. Dr. Chen removed his glasses and polished them on the hem of his coat, a slow, deliberate motion that filled the silence.

“No one authorized it,” I said. “Because we don’t have a procedure for that.”

Sean’s jaw worked. “Then write one. After we finish the data package.”

“After we finish the data package, the data package won’t be worth anything if the thermal evidence says the actuator housing is degrading.” I kept my voice level. “The review board will see the same spikes we just saw. If we can’t explain them, they’ll reject the validation.”

Dr. Chen put his glasses back on. “Chloe is correct. The catheter’s safety evidence has to stand on its own. You can’t borrow data from the biometric band to fill gaps in the catheter file, and you can’t use the catheter’s clinical promise to excuse a materials risk you haven’t resolved. They’re separate products. They require separate standards.”

“I’m not asking to borrow anything,” Sean said. “I’m asking to finish the run.”

“And I’m telling you the run shouldn’t be finished until the heat spike is understood.” Dr. Chen’s voice didn’t rise, but it didn’t yield either. “You brought me here to assess the evidence. This is my assessment.”

Linnea pulled her hands out of the housing and straightened. “The actuator casing is discolored. I can’t tell from a visual inspection whether it’s surface oxidation or the start of structural breakdown. I’ll need to run a materials analysis before I clear the bench for another test.”

Sean stared at the housing. The chemical smell was fading now, pulled out by the ventilation, but it lingered enough to remind everyone in the room what had happened.

“How long?” he asked.

“I don’t know yet.”

“Give me an estimate.”

“I said I don’t know.” Linnea peeled off her gloves, one finger at a time, and set them on the bench beside the tablet. “I’ll tell you when I do.”

Sean looked at me. I held his gaze and didn’t offer him a different answer, because there wasn’t one. The run was stopped. The heat spike was real. The smell had been real. And no one in the room could say whose authority decided what happened next.

“Fine,” Sean said. He didn’t put the tablet down, but his thumb stopped moving over the screen. “Figure it out. But this doesn’t leave the building until we know what we’re reporting.”

He turned and walked out of the bay. The door closed behind him with a soft pneumatic hiss.

Dr. Chen exhaled slowly. “He’s not wrong about the urgency. But urgency doesn’t make the evidence more reliable.”

“I know,” I said.

Linnea was already typing on her tablet, logging the shutdown sequence, the temperature readings, the time the odor was first detected. I watched her work and thought about the gap between what Sean needed to hear and what the data actually said. The gap had been there for weeks. I’d been filling it with schedules and staffing lists and careful language, and now the gap was a burned actuator housing and a smell none of us could explain.

I closed my notebook. “Linnea, when you’ve finished the documentation, send me the thermal logs. I want the full run data, not the summary.”

“You’ll have it in an hour.”

“Dr. Chen, can you review the pressure curves from the earlier runs? If those are solid, we can at least tell Sean what part of the evidence isn’t in question.”

He nodded. “I’ll have notes for you by tomorrow.”

I looked at the testing cradle, at the catheter still resting in its housing, at the tablet still scrolling through the shutdown diagnostics. “The next test doesn’t start until we have written stop criteria. I don’t care if it costs us a day. We’re not doing this again.”

Linnea glanced up from her tablet. For a moment her expression was unreadable, and then she gave a single short nod. “Good.”

I tucked my notebook under my arm and walked toward the bay door. The ventilation was still running, pulling the last of the smell out through the ducts, and the sound of it followed me into the corridor like a question nobody had finished asking.

The office was quieter than it should have been at five thirty on a Wednesday.

I noticed it first in the kitchenette, where the electric kettle sat cold and two mugs from yesterday still waited in the drying rack, untouched. The workstations were lit but three of them held only the residue of departure: a keyboard pushed back at an angle, a chair that hadn’t been tucked in, a company hoodie draped over an armrest where someone had decided not to take it. The reorganization had been underway for two days. The reorganization was no longer a spreadsheet.

Sean was at the far end of the floor, his tablet propped against a monitor stand, scrolling through catheter bench data with his sleeves pushed up. He hadn’t looked at me when I came in. He was still not looking at me now.

“We’re missing people,” I said.

“I noticed.”

I set my notebook on my desk and uncapped my pen. The staffing list was still tucked inside the cover, the names I’d penciled in on Monday now crossed through and rewritten twice. Kai and Wei were on the catheter bench at Nangang, which was where they were supposed to be. The three empty workstations belonged to the firmware team.

“They left notes?” Sean asked.

“Two of them did.” I pulled the folded sheets from my bag. The first was a single line on printer paper: I can’t build the catheter when I was hired for the band. The second was longer, handwritten, the ink pressed hard enough to leave grooves. The band was the reason I said yes. You’re asking me to work on something I didn’t choose and don’t believe in the same way. I won’t do it.

Sean read both without changing expression. “And the third?”

“No note. His desk is clean.”

“Fine.” He handed the papers back. “We replace them.”

“With who? The catheter trial is on a regulatory clock. New hires need training. We don’t have bench hours for onboarding and we don’t have payroll for overtime.” I kept my voice level. I had practiced the sentence twice in the stairwell. “The staffing list is already below minimum for the Friday deadline.”

Sean’s thumb moved across his tablet. “The Friday deadline doesn’t move.”

“I know.”

“Then find the hours.”

I didn’t answer. The three empty chairs sat behind him like an exhibit, and he hadn’t turned to look at them once. I opened the staffing list and drew a line through the firmware team’s names. Beneath them I wrote gap: 3 and circled it.

The office door opened behind me.

It was the catheter validation lead, a woman named Ruoxi who had been with Aetheris since the first animal trial. She was carrying a slim folder and her work badge was already unclipped from her collar, held loose in her other hand. I saw the badge before I saw her face.

“I need to talk to you,” she said. She was looking at me, not at Sean.

Sean turned. “Talk to both of us.”

Ruoxi hesitated. She was standing in the gap between the kitchenette and the first row of workstations, and she didn’t move to close it. “I’m leaving.”

“When?” I asked.

“Now. Tonight.” She set the folder on the nearest desk. “The trial protocols are in there. All the bench logs through yesterday. I updated the compliance checklist this morning.”

Sean stepped forward. “The catheter data package is due Friday. You’re the validation lead.”

“I know what I am.” Ruoxi’s hand stayed on the folder. “I also know the catheter is a Class III device going into human trials, and I know the bench-hour policy Chloe wrote after Kai’s third late night. I read it. I agreed with it.” She looked at me again. “The reorganization has me running validation on a schedule that violates that policy twice over. I told you this yesterday. You said you’d take it to Sean.”

I had. Sean had said the deadline didn’t move.

“The policy was written for normal operations,” Sean said. “This is a funding runway. It’s temporary.”

“Temporary doesn’t make a bench error disappear.” Ruoxi unclipped her badge from her collar and laid it on top of the folder. “I’m not signing validation reports I can’t stand behind. And I’m not staying to watch someone else sign them.”

She walked out. The door clicked shut, and the sound was smaller than I expected, a neat mechanical latch that didn’t echo.

Sean stared at the folder. “She took her badge off.”

“Yes.”

“Four people. In one afternoon.”

“Three in the afternoon,” I said. “Ruoxi makes four. And the trial validation paperwork is now sitting on a desk with no one to sign it.”

He turned back to his tablet. I watched his shoulders set, the way they did before he issued a deadline, but no deadline came. The tablet screen was dark. He hadn’t woken it.

I walked to my workstation and sat down. The compliance checklist was in my notebook, the 37-item version I’d built after the safety review. I unfolded it and scanned the catheter trial section. Validation lead: Ruoxi. Bench-hour ceiling: 12 per technician per 24-hour period. Current staffing: minus four. The math was simple. The math didn’t care about Friday.

My phone buzzed.

The notification was from the TFDA portal. I’d set alerts for the catheter trial docket three months ago, back when the review board had first scheduled the 15th, and the subject line on this one was different from the usual meeting-minutes update. I opened it.

Order to Cease Clinical Investigation Activity.

I read it twice. The language was precise, the kind of regulatory prose that left no room for interpretation. Effective immediately, all clinical investigation activity related to the above-referenced device is halted pending completion of an expedited safety review. No new subjects may be enrolled. No data may be collected from enrolled subjects. No investigational device may be implanted or activated. The grounds were listed in a numbered paragraph: the review board had flagged inconsistencies in the bench validation records and was initiating a full audit. The order was signed by the TFDA division chief.

I set the phone down on my desk.

“Sean.”

He looked up.

“The catheter trial is stopped.” I read the order aloud, all of it, the numbered paragraphs and the signature block and the effective-immediately clause. When I finished he was holding his tablet against his thigh, his thumb still.

“When did that come in?”

“Three minutes ago.”

“The validation records. That’s what they’re auditing.”

“Yes.”

“Ruoxi just walked out with the validation records sitting on that desk.”

“She left the folder. The records are here.” I picked up the folder and opened it. The bench logs were in order, dated and signed, but the final validation report was blank. Ruoxi hadn’t signed it. No one had.

Sean set his tablet down. “Call the review board. Ask for an expedited review timeline.”

“The order says the audit is already underway. I can’t expedite something that’s already moving.”

“Then ask what they need from us to lift the stop.”

“I can do that.” I opened my notebook to a fresh page. “But the order is clear. No new subjects, no data collection, no implantation. The Friday deadline requires bench data we’re not allowed to gather.”

“The funding requires the catheter to be on track. Victor’s term sheet arrived this morning. I read it.”

I hadn’t seen the term sheet. Sean had kept it on his tablet, face-down until a decision point, the same way Victor had placed his phone during the video call. “What does it say?”

“Twenty-five million, contingent on the catheter data package by Friday and a clear path to trial completion. If the trial is halted, the path isn’t clear.”

“The trial is halted.”

“I know.” His voice tightened. “That’s the problem.”

I looked at the empty workstations, the four chairs that had been occupied this morning. The firmware team’s notes were still on my desk, Ruoxi’s badge on top of her folder, the compliance checklist open to a page full of names that no longer matched the people in the room. The stop-order was on my phone, and the term sheet was on Sean’s tablet, and the two documents contradicted each other in a way that no scheduling adjustment could fix.

“Sean, I need to send the stop-order to the people who are still here.”

“Why?”

“Because they’re still running bench tests at Nangang. Kai and Wei are on the catheter bench right now, and the order says no investigational device activity. They need to stop.”

He didn’t answer. His hand was on his tablet, the screen still dark.

“I’m not asking permission,” I said. “I’m telling you what the regulator requires.”

I forwarded the TFDA notice to the full staff list. Kai, Wei, the two technicians still on the band project, the office administrator, Sean. The subject line was the same one the TFDA had used. I added one line at the top: All catheter bench work stops as of this notice. Confirm receipt.

My phone buzzed within thirty seconds. Kai: Confirming. Shutting down bench now. Wei: Received. Bench is cold.

Sean read the forward on his own phone. He didn’t respond to the thread.

“You just told the whole company the trial is dead,” he said.

“I told them the trial is halted pending a safety review. That’s what the order says.”

“Victor will pull the offer if he hears the trial is stopped.”

“Victor will pull the offer if we violate a TFDA stop-order and lose our clinical trial authorization entirely.” I capped my pen. “One of those is recoverable. The other is a permanent disqualification.”

He was quiet. The office hummed with the ventilation fans, the only sound left now that the workstations were empty and the bench was cold and the four people who’d walked out weren’t coming back. I watched Sean’s hand rest on his tablet, his knuckle pressed against the dark glass, and I thought about the term sheet he hadn’t shown me, the twenty-five million contingent on a clear path that no longer existed.

“Friday is two days away,” he said.

“I know.”

“The audit could take weeks.”

“It could.”

“Then what do I tell Victor?”

I closed my notebook. The staffing list was still inside, the crossed-out names and the gap count and the compliance checklist with its bench-hour ceiling intact. None of it mattered until the stop-order was lifted, and the stop-order would not be lifted by urgency.

“You tell him the truth,” I said. “The catheter trial is halted by regulatory order. The company is complying. And the Friday deadline is no longer a deadline we can meet.”

Sean looked at me. His expression was the same one he’d worn when Ruoxi walked out, the same one he’d worn when I’d read the stop-order aloud, a stillness that wasn’t calm. He didn’t argue. He didn’t issue a new deadline. He just stood there with his tablet in his hand and the empty office behind him, and I realized I had stopped buffering. I had stopped translating his urgency into something the staff could absorb. I had put the order in front of him and refused to reduce it.

He walked to the meeting room and closed the door. Through the glass I saw him pick up his phone.

I stayed at my desk. The TFDA order was still open on my screen, the words effective immediately in bold at the top of the page. Ruoxi’s folder sat beside my keyboard, her badge still on top of it, the photo slightly worn at the edges from two years of swiping into the building. I picked up the badge and set it inside the folder, next to the unsigned validation report.

The ventilation fans cycled off, then on again. Outside the window the Neihu skyline was going dark, the office towers lighting up floor by floor. I reopened my notebook to a clean page and wrote the date at the top. Beneath it I wrote stop-order received, and then I stopped, because I didn’t know what came next.

The afternoon light had turned thin and grey through the office windows, the kind of February overcast that made the fluorescent panels overhead feel harsher than they needed to be. I’d been at my workstation since seven, and the compliance checklist still sat open to the same page I’d marked two days earlier, its margin notes multiplying in my handwriting. The bench-hour limit I’d written into protocol after Kai’s three late nights was still there, underlined twice, but it hadn’t been tested yet. No one had asked to exceed it. No one had needed to. That was about to change.

Sean was already in the meeting room, adjusting the video-call setup with the quick, impatient movements of someone who’d rather be anywhere else. He wore the same Stanford hoodie he’d worn all week, the cuffs fraying, and his tablet was propped against a stack of catheter documentation I’d printed for him that morning. The data package was due Friday. The hospital review board met on the fifteenth. Every hour between now and then was spoken for, and Sean had been treating that scarcity as a reason to move faster, not to ask what the speed was costing.

“Victor’s dialing in,” he said, not looking up. “Sit.”

I sat. My notebook was open to a fresh page, the pen uncapped. I’d carried the team’s workload concerns forward from Monday’s staffing grid, but I hadn’t found a way to put them before Sean without making the company’s finances harder to defend. The payroll balance I’d checked at the start of the week left almost no room, and Sean’s answer to that fact had been the Friday deadline. He saw a cash problem and reached for a technical deliverable. I saw the same problem and reached for the people who’d have to produce it.

The screen flickered once, and Victor Chen appeared.

He was sitting in what looked like a Hong Kong conference room, the kind with floor-to-ceiling glass and a skyline behind it that cost more per square foot than our entire Neihu lease. His suit was charcoal, sharply cut, and his phone sat face-down on the table beside a single sheet of paper. He didn’t smile when the connection stabilized. He waited for Sean to speak first, which was its own kind of signal.

“Victor,” Sean said. “Thanks for making the time.”

“The time was already made.” Victor’s voice was compact, polished, every syllable placed. “Let’s not use more of it than we need. You know why I’m calling.”

Sean’s hand moved toward his tablet, then stopped. “The Series B.”

“Twenty-five million.” Victor let the number sit. “Horizon Apex is prepared to lead the round, but the terms are not what we discussed in December. The market has shifted. Your burn rate is higher than your milestones support. The biometric band is a consumer play with no regulatory pathway and no revenue forecast that holds up to scrutiny. I’m not going to fund both.”

I wrote the figure down. Twenty-five million. It was more than we’d raised in the seed and Series A combined. It was enough to keep the lights on for two years, to finish the catheter trials, to hire the second shift of technicians Kai and Wei had been covering for with their own sleep. It was also, Victor was making clear, a choice.

“You want us to shelve the band,” Sean said.

“I want you to survive. The catheter has a clinical endpoint, a review board date, and a path to approval. The band has none of those things. If you focus on the medical device, you can prove it works and you can do it on a timeline that justifies the capital. If you keep splitting your engineering resources, you’ll miss both targets.” Victor’s gaze shifted, and I realized he was looking at me. “Chloe, you’re the one who tracks the hours. Am I wrong?”

He knew my name. I hadn’t expected that, and the surprise of it made me answer more carefully than I might have otherwise. “The team is stretched. The catheter data package is consuming most of the bench time. The band has been running on whatever’s left.”

“Which is how much?”

I glanced at my notebook, though I already knew the number. “Less than a third of the scheduled hours this month. And the scheduled hours were already thin.”

Victor nodded once, as if I’d confirmed something he’d already priced in. “The offer is conditional on the band being paused. Not killed. Paused. If the catheter reaches its milestones, we can revisit the consumer line. But for now, Aetheris is a medical-device company or it’s nothing.”

Sean was quiet for a long moment. I watched his hand on the tablet, the way his thumb tapped the edge of the screen twice and then went still. He was doing the math I’d already done. The band was the promise we’d built the company on, the green pulse that said medicine didn’t have to hurt, that a body could be read without a needle or a waiting room. Shelving it wasn’t a pause. It was an admission that the promise couldn’t pay for itself yet.

“We’ll do it,” Sean said.

His voice had the flatness of a decision that had already been made, maybe before Victor even dialed in. He turned to me, and the shift in his posture was small but complete. He wasn’t asking. He was directing.

“Reorganize around the catheter. All bench hours, all documentation, all review prep. The band goes into maintenance mode. I want a revised staffing plan by end of week.”

I didn’t argue. The number was twenty-five million, and arguing with a lifeline looks like not wanting to be saved. But I didn’t start writing his instructions down either. Not yet.

“I’ll need a transition schedule,” I said. “One that records the staffing limits we already have in protocol. If we’re moving everyone onto the catheter, the bench-hour ceiling still applies. Otherwise we’ll burn through the team before the review board even sees the data.”

Sean’s jaw tightened. “Fine. Document it.”

“And the safety review.” I kept my voice even, the way I’d learned to do when the thing I was saying wasn’t what he wanted to hear. “It was designed to cover both products. If the band is being shelved, I need to know whether the review stays consistent across the development work that’s still active, or whether we’re going to treat consumer testing and clinical validation as separate processes with different standards.”

Victor cut in before Sean could answer. “That’s an operational question. I don’t dictate your internal protocols. But I will say this: the catheter is a Class III device. Its safety review is not the same thing as a consumer-product checklist, and if you try to make it the same, you’ll fail the hospital’s scrutiny. Keep them separate.”

I wrote that down. Keep them separate. It was the answer I’d expected, but hearing it from Victor made it land differently. He wasn’t just asking us to pause the band. He was asking us to treat the two products as if they’d never belonged in the same company, and the people who’d been moving between them as if their expertise could be split down the middle.

“The transition schedule will reflect that,” I said. “Separate review tracks. Separate hour allocations. But the staffing limits stay. I’m not going to document a plan that assumes Kai and Wei can work catheter hours and band maintenance without hitting the ceiling.”

Victor’s expression didn’t change. “That’s your call. I’m not here to manage your bench.” He picked up his phone, turned it over once, and set it down again. “The term sheet will be in your inbox by tonight. Sean, I’ll expect a response by Monday.”

“You’ll have it,” Sean said.

The screen went dark. The meeting room felt smaller without Victor’s skyline filling the wall, and the hum of the air conditioning filled the space where his voice had been. Sean didn’t move for a moment. Then he picked up his tablet and stood.

“The catheter gets everything,” he said. “Make it work.”

He walked out before I could answer, which was probably the point. I stayed at the table, my pen still uncapped, the notebook open to a page that now had twenty-five million written at the top and a list of tasks forming beneath it. Reorganization. Transition schedule. Staffing limits. Separate safety tracks. Each item was a thing I knew how to do, and each one carried a cost I hadn’t yet found a way to name aloud.

I opened the staffing list. Kai and Wei’s names were still there, their hours penciled in from Monday, the bench ceiling I’d fought for already pressing against the new reality Sean had just handed down. The band was being shelved, but the people who’d built it weren’t, and the question I hadn’t answered yet was what they were going to be asked to give up in order to keep the catheter on schedule. I drew a line under their names and started writing.

The green light was already pulsing when I unlocked the office door. The biometric band sat on its stand near the window, a silicone loop no wider than a watch strap, blinking at the empty workstations with a rhythm that was supposed to mean alive. It had been blinking for six months now, through two payroll scrambles and a round of supplier calls I’d made from the kitchenette floor because my desk chair had broken and I hadn’t wanted anyone to see me sitting on a stack of compliance binders.

The band was the promise we’d made when Aetheris still sounded like a name instead of a bet. A wearable that read your body without needing a needle, a lab visit, a waiting room. The catheter came later, after the hospital advisory panel told Sean what they’d need to see before any surgeon would touch a device with our name on it. I’d written the date of that meeting in my notebook and underlined it twice. April 14. The day the band stopped being the product and started being the proof.

I set my bag on my chair and checked the thermostat. The air conditioning hadn’t kicked in yet, and the room had that early stillness I’d come to depend on, the forty minutes before anyone else arrived when I could read through the overnight emails without someone asking me what was wrong. Nothing was wrong. Nothing was ever wrong until it was.

The payroll balance sat in my inbox where I’d left it the night before, a number I’d already subtracted from three times in my head. I’d budgeted through the end of the quarter, but the quarter ended in five weeks, and the catheter’s next test cycle needed two more bench runs before the data package would be clean enough for the hospital review board. The bench runs needed Kai and Wei. Kai and Wei needed salaries.

I closed the email and opened my notebook instead. The pages fell open to the staffing grid I’d drawn on Friday, names in blue ink, shifts in black, gaps circled in red. I’d been redrawing versions of this grid since we moved into the Neihu office, back when the floor still smelled like paint and Sean had stood in the middle of the empty room and said, “This is where we build it.” He’d meant the band. He’d been wearing the same Stanford hoodie he’d worn to our first investor meeting, the one where the venture partner had asked him if he’d brought a jacket and Sean had said, “I brought a prototype.”

The door opened behind me.

I didn’t turn around. The footsteps were quick and light, two at a time, and I heard the rustle of a lab coat being shrugged off before I heard Kai’s voice.

“Chloe, you’re here early.”

“I wanted to check the schedule.” I turned the page so he wouldn’t see the payroll number if he came around the desk. “You’re early too.”

Kai Huang was twenty-three, wiry, and perpetually in motion. He’d come to us from a polytechnic program in Taichung, and he still wore the club T-shirt from his final project team under his lab coat, the collar frayed from washing. A black marker sat tucked behind his left ear, and I’d never once seen him without it. He pulled out the chair at the workstation nearest mine and sat on it backward, arms folded across the top.

“Couldn’t sleep,” he said. “I was thinking about the handoff. The catheter test from yesterday. Wei logged the results, but I wanted to go over the timing with you before Sean gets in.”

“Go ahead.”

“It’s taking longer than we planned. The second bench run ran into the afternoon, and we lost an hour recalibrating the pressure sensor. Wei’s got the exact numbers, but I think we’re half a day behind where the schedule says we should be.” He tapped his fingers on the back of the chair. “I can stay late tonight. Catch it up.”

He said it the way someone offers to pick up milk on the way home. A small thing. An obvious fix.

“Let’s wait until Wei gets here,” I said. “I want to see his logs before we decide anything.”

Kai nodded, already turning toward his terminal. “I told him I’d be here. He’s probably on the train.”

Wei Liao arrived twelve minutes later. I knew it was him before the door opened because the footsteps stopped outside, and I could picture him wiping his shoes on the mat even though the hallway was clean. He came in carrying a binder with a labeled spine and set it on his desk before he said good morning. His side part was precise, his shirt pressed, his fingertips stained faintly blue from the carbon paper he insisted on using for his backup logs. He was twenty-four and had an engineering degree from a university in Hsinchu, and he logged everything twice.

“Morning,” I said.

“Morning.” He opened the binder. “The pressure sensor calibration took fifty-three minutes, not an hour. I have the start and stop times on page fourteen.”

Kai leaned over from his chair. “Fifty-three minutes is basically an hour.”

“It’s fifty-three minutes.” Wei looked at me. “The delay was real, but it’s smaller than Kai’s estimate. The bench run finished at four-twelve. I logged it before I left.”

I walked over to his desk and looked at the page he’d opened to. The numbers were written in neat rows, each entry timed and initialed. Wei’s logs were the reason I’d stopped checking the catheter’s test data myself. I trusted his records more than my own notes.

“So we’re behind by half a day,” I said. “Closer to a third.”

“If we adjust tomorrow’s schedule, we can recover by Thursday,” Wei said. “The morning bench is already blocked for calibration. We can fold the extra run into that slot.”

Kai turned around from his terminal. “Or I stay late tonight and we’re caught up by tomorrow morning. Either way works. I don’t mind.”

Wei didn’t answer right away. He was looking at his binder, but I could see him doing the arithmetic, weighing the precision of the schedule against the cost of the extra hours. When he spoke, his voice was quieter than Kai’s, the words placed one at a time.

“The schedule is a plan. Plans can be corrected.”

I looked at the two of them, Kai already half out of his chair and ready to volunteer another shift, Wei trusting that the logs would hold the answer if he kept them accurate enough. They both assumed the work would get done because they were willing to do it. That assumption was a gift they were giving the company, and it was also a debt the company was racking up, and I was the one who kept the ledger.

“Let me talk to Sean first,” I said. “Don’t change anything yet.”

I went back to my desk and opened the compliance checklist. The catheter’s regulatory filing was due in six weeks, and I’d been working through the safety documentation line by line, flagging gaps before the hospital review board found them for us. There were thirty-seven items on the list. Twelve were marked green. The rest were yellow or blank. I read through the staffing section again and made a note in the margin about maximum bench hours per technician per week. The number was a policy, not a law, but I’d written it into our internal protocols after the first time Kai had worked three late nights in a row and I’d found him asleep at his terminal the next morning.

The office door opened a third time, and this time I did turn around.

Sean Lin walked in wearing the same hoodie and carrying a tablet in one hand, the screen already lit. He was lean and fast-moving, and he checked his watch before he’d finished crossing the room, as if the morning had already fallen behind. He was twenty-nine, a year younger than me, but he carried himself like someone who’d been given a deadline he hadn’t agreed to and was determined to beat it anyway.

“Chloe. The handoff.” He stopped at my desk. “Kai said there’s a delay.”

I hadn’t sent him an update. I’d been planning to frame it after I’d looked at Wei’s logs and decided how much of the workload concern needed to reach him. But Kai must have messaged him from the train, or Sean had checked the shared calendar and done the subtraction himself.

“The bench run finished late yesterday,” I said. “Wei’s got the exact times. It’s manageable.”

“How manageable?”

“A third of a day. We can fold the recovery into tomorrow’s calibration block.”

Sean didn’t sit down. He never sat down in the mornings. He stood at the edge of my desk and read something on his tablet, and I could feel him already moving past the delay and into the next thing, the thing the delay was blocking.

“The data package has to be ready by the end of next week,” he said. “The hospital review board meets on the fifteenth. If we’re still adjusting the schedule when they open the file, they’re going to ask what else we’re adjusting.”

“I know the deadline.”

“Then the delay is a deadline. Friday. The bench runs need to be done by Friday, or the data package doesn’t go out.” He looked up from the tablet. “Tell Kai and Wei. They can add hours tonight and tomorrow. We’ll buy the time back.”

I opened my notebook to the staffing page. The compliance checklist sat underneath it, the thirty-seven items, the margin note about bench hours, the yellow and blank rows. I’d been holding the workload concern away from Sean because I’d wanted to solve it before it became his problem. But he’d found it anyway, and his solution was the one I’d been trying to avoid.

“Before anyone adds hours,” I said, “I want to run a safety review.”

“A safety review.”

“The catheter’s a Class III device. If we push the bench runs without checking the staffing load against the protocol, we’re creating a compliance gap. The review board will flag it.”

Sean looked at me for a moment. His expression didn’t change, but I saw him register the word I’d chosen, compliance, the one thing he couldn’t override with a deadline. I wasn’t challenging his authority. I was citing the rules we’d both agreed to follow.

“How long will the review take?”

“A day. Maybe less, if Wei’s logs are current.”

“Fine. Run it today. But the deadline doesn’t move.” He turned toward his workstation. “Friday, Chloe.”

I watched him walk to his desk and set the tablet down. Kai had gone quiet at his terminal. Wei was still looking at his binder, but his hand had stopped on the page, and I knew he’d heard the whole exchange.

I looked down at my notebook. The staffing grid was still open, the red circles still waiting. I’d kept the workload concern out of Sean’s update, and he’d turned the concern into a deadline anyway. The safety review would buy me a day, maybe two, but it wouldn’t answer the question that had been sitting in the back of my mind since I’d unlocked the office door.

Who decided when the work was moving too fast? Sean set the schedule. I managed the checklist. But the checklist only worked if someone used it before the hours got added, and Sean had just made it clear that the hours would get added regardless.

Kai pushed his chair back. “Chloe, the review. Should I pull the calibration logs for the last two weeks?”

“Yes. And the bench-hour totals. I want to see how many late nights are already in the record.”

He nodded and turned back to his terminal. Wei closed his binder and stood up, and I saw him glance toward Sean’s desk before he spoke.

“The logs are ready. I can have the summary on your desk by ten.”

“Thank you.”

I closed the notebook and set it on top of the compliance checklist. The green light from the band pulsed once in my peripheral vision, steady and indifferent, marking a promise we’d made before the deadlines started piling up. I’d told myself I could keep the team moving and keep them safe at the same time, that the buffer I built between Sean’s urgency and the staff’s exhaustion was enough. But the buffer was made of my own willingness to absorb the pressure, and pressure absorbed doesn’t disappear. It sits somewhere, waiting to be named.

I opened the checklist again and started reading.